Relevant bibliographies by topics / Respiratory infections - Homeopathic treatment

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Respiratory infections - Homeopathic treatment'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Respiratory infections - Homeopathic treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Respiratory infections - Homeopathic treatment"

1

Fixsen, Alison. "Homeopathy in the Age of Antimicrobial Resistance: Is It a Viable Treatment for Upper Respiratory Tract Infections?" Homeopathy 107, no. 02 (2018): 099–114. http://dx.doi.org/10.1055/s-0037-1621745.

Full text
Abstract:
Background Acute upper respiratory tract infections (URTIs) and their complications are the most frequent cause of antibiotic prescribing in primary care. With multi-resistant organisms proliferating, appropriate alternative treatments to these conditions are urgently required. Homeopathy presents one solution; however, there are many methods of homeopathic prescribing. This review of the literature considers firstly whether homeopathy offers a viable alternative therapeutic solution for acute URTIs and their complications, and secondly how such homeopathic intervention might take place. Method Critical review of post 1994 clinical studies featuring homeopathic treatment of acute URTIs and their complications. Study design, treatment intervention, cohort group, measurement and outcome were considered. Discussion focused on the extent to which homeopathy is used to treat URTIs, rate of improvement and tolerability of the treatment, complications of URTIs, prophylactic and long-term effects, and the use of combination versus single homeopathic remedies. Results Multiple peer-reviewed studies were found in which homeopathy had been used to treat URTIs and associated symptoms (cough, pharyngitis, tonsillitis, otitis media, acute sinusitis, etc.). Nine randomised controlled trials (RCTs) and 8 observational/cohort studies were analysed, 7 of which were paediatric studies. Seven RCTs used combination remedies with multiple constituents. Results for homeopathy treatment were positive overall, with faster resolution, reduced use of antibiotics and possible prophylactic and longer-term benefits. Conclusions Variations in size, location, cohort and outcome measures make comparisons and generalisations concerning homeopathic clinical trials for URTIs problematic. Nevertheless, study findings suggest at least equivalence between homeopathy and conventional treatment for uncomplicated URTI cases, with fewer adverse events and potentially broader therapeutic outcomes. The use of non-individualised homeopathic compounds tailored for the paediatric population merits further investigation, including through cohort studies. In the light of antimicrobial resistance, homeopathy offers alternative strategies for minor infections and possible prevention of recurring URTIs.
APA, Harvard, Vancouver, ISO, and other styles
2

Dixit, Ashish Kumar, Shishir Singh, and Subhas Singh. "Efficacy of Homoeopathy in Managing Respiratory Infections beyond Doubt!—A Narrative Review." Homœopathic Links 33, no. 04 (2020): 249–56. http://dx.doi.org/10.1055/s-0040-1715635.

Full text
Abstract:
Abstract Background Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is accountable for significant mortality worldwide. This virus is primarily infecting the respiratory tract and resulting in SARS. There is no precise treatment available till today. Thus, it is important to find out the alternative approach which can reduce the burden of disease. Objective The aim of this review is to summarise and appraise the findings of various studies on respiratory infections in homoeopathy. Methods A comprehensive search of the articles published during the period from 1 January 2000 to 15 June 2020 on homoeopathy and respiratory infections was carried out. Major electronic medical databases such as PubMed, Cochrane Database of Systematic Reviews, CORE-Hom and CAM-QUEST were used for the literature search. Result From the literature search 46 studies congregated out of which 9 were systematic reviews, 18 randomised contolled trials, 1 controlled clinical trial, 13 comparative cohorts, 3 single-arm cohort observational studies, 1 case series and 1 case report. The results of this review are encouraging. Homeopathic medications have a positive effect in reducing the number of attacks of respiratory infections, less antibiotic usage, tolerability and good compliance as compared to conventional treatment. Complex homeopathic medicine showed a promising role in combating respiratory infections. Homeopathy has shown an important role as adjuvant therapy. Conclusion The findings of this review seem to suggest a definite role of homeopathy beyond placebo in the treatment of various conditions of respiratory infections. Applying homeopathy as an adjunctive treatment in COVID-19 cases can be cost-effective, feasible and safe. Owing to the heterogeneity in trials, independent replications and further appraisal with rigorous designs are warranted.
APA, Harvard, Vancouver, ISO, and other styles
3

Hasan, Nazmul, Mesbah Uddin Md Rezwanun Nayem, Mohammad Mohshinuzzaman, et al. "Homeopathic Approach to COVID-19: A Review." Malaysian Journal of Medical and Biological Research 7, no. 1 (2020): 39–44. http://dx.doi.org/10.18034/mjmbr.v7i1.493.

Full text
Abstract:
Novel coronavirus 2019-nCoV-2 infection, also known as COVID-19, has a pandemic outbreak, and recent studies show various limitations, including treatment. This virus is chiefly infecting the respiratory tract (RTI) and resulting in Severe Acute Respiratory Syndrome. Many developed countries, including Italy, England, and the United States of America (USA), are facing many casualties. Unlikely, no specific treatment protocol is available till today. Homeopathic medicine is a branch of alternative medicine, practiced on individualized symptoms similarity. However, historically it has potential in treating epidemic infections like scarlet fever, typhoid, and cholera. In the treatment of RTI and pneumonia, several homeopathic medicines have proven efficacy. This review on the utility of homeopathic medicine might guide the physician to prevent COVID-19 contagion. Homeopathic medicines can help humanity with conventional medical methods to prevent this global catastrophe.
APA, Harvard, Vancouver, ISO, and other styles
4

Hasan, Nazmul, Mesbah Uddin Md Rezwanun Nayem, Mohammad Mohshinuzzaman, et al. "Homeopathic Approach to COVID-19: A Review." Malaysian Journal of Medical and Biological Research 7, no. 2 (2020): 81–86. http://dx.doi.org/10.18034/mjmbr.v7i2.493.

Full text
Abstract:
Novel coronavirus 2019-nCoV-2 infection, also known as COVID-19, has a pandemic outbreak, and recent studies show various limitations, including treatment. This virus is chiefly infecting the respiratory tract (RTI) and resulting in Severe Acute Respiratory Syndrome. Many developed countries, including Italy, England, and the United States of America (USA), are facing many casualties. Unlikely, no specific treatment protocol is available till today. Homeopathic medicine is a branch of alternative medicine, practiced on individualized symptoms similarity. However, historically it has potential in treating epidemic infections like scarlet fever, typhoid, and cholera. In the treatment of RTI and pneumonia, several homeopathic medicines have proven efficacy. This review on the utility of homeopathic medicine might guide the physician to prevent COVID-19 contagion. Homeopathic medicines can help humanity with conventional medical methods to prevent this global catastrophe.
APA, Harvard, Vancouver, ISO, and other styles
5

Buskin, Stephen, Maria Pilar Riveros Huckstadt, and Silvia Salatino. "Use of natural and homeopathic remedies in children ailments." Clinical Management Issues 10, no. 2 (2016): 33–48. http://dx.doi.org/10.7175/cmi.v10i2.1252.

Full text
Abstract:
In recent decades the use of CAM (Complementary and Alternative Medicine) has increased significantly, not only among adults but also in the pediatric population. Perceived efficacy of homeopathic or natural treatments, fear of drug adverse effects, dissatisfaction with conventional medicine, and the need for more personal attention are the main reasons given by parents who treat their children with homeopathy.In the present paper the use of natural and homeopathic remedies for the treatment of children ailments are considered. In particular we focus on minor disorders of early childhood with a major impact on the well-being of the whole family, namely infant colic, teething, upper respiratory tract infections (URTIs) and tonsillopharyngitis. The results of recent studies on homeopathic products for the treatment of these disorders are be presented and discussed.
APA, Harvard, Vancouver, ISO, and other styles
6

Savenkova, M. S. "Opportunity of Homeopathic Drug Aflubin Use in the Treatment of Acute Respiratory Viral Diseases in Children." Effective Pharmacotherapy 16, no. 34 (2020): 10–14. http://dx.doi.org/10.33978/2307-3586-2020-16-34-10-14.

Full text
Abstract:
The article presents the literature data on the homeopathic drug Aflubin use for the complex treatment of influenza and acute respiratory viral infections in children, the opportunity of its use in the epidemic period of respiratory diseases, as well as in the form of a preventive tool. Summarized data concerning the main properties of the drug. The ingredients that make up the drug, affect the reduction of intoxication and temperature symptoms, contribute to the relief of coughing and pain. Aflubin can be used in children starting from the first year of life
APA, Harvard, Vancouver, ISO, and other styles
7

Das, Abhishek, Shubhamoy Ghosh, Satadal Das, et al. "Introspecting Scope of Ultra-Diluted Homeopathic Preparations in Human SARS-CoV-2 Infection: A Perspective Review." Homœopathic Links 34, no. 02 (2021): 112–18. http://dx.doi.org/10.1055/s-0041-1732782.

Full text
Abstract:
AbstractCoronavirus disease 2019 (COVID-19) is a zoonotic disease caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Its symptoms range from mild fever, cough, pharyngitis to severe acute respiratory syndrome. Since its first outbreak in Wuhan province of China, the disease has spread worldwide and emerged as pandemic. The infection is mainly spread by droplets and through contacts. Initially SARS-CoV-2 was thought to cause viral pneumonia only, but now it is evident that the virus can spread through the bloodstream and can cause systemic lesions as well. Though most of the time patients recovered spontaneously for immune-compromised patients, it is detrimental. Lack of effective therapy in conventional medicine has made host immune response as the only option to focus on this battle against COVID-19. First-world countries such as the USA, Italy, England and Spain have witnessed a massive number of deaths, and India is not an exception to that. The whole world is searching for effective treatment in the form of antiviral drugs, vaccines and hydroxychloroquine, but none has proven effective. Homeopathy has always put a mark during epidemics and in recent past during the elimination of leptospirosis in Cuba (2009–2014), homeopathy was very effective. In this scenario, we think homeopathy has a decisive role to play to fight this pandemic as it can enhance the host immune response and reduce the severity of the infection to a great extent. In this review, we will discuss the scopes of homeopathic medicines in the treatment of coronavirus disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Thinesse-Mallwitz, Manuela, Vitaly Maydannik, Thomas Keller, and Petra Klement. "A Homeopathic Combination Preparation in the Treatment of Feverish Upper Respiratory Tract Infections: An International Randomized Controlled Trial." Complementary Medicine Research 22, no. 3 (2015): 163–70. http://dx.doi.org/10.1159/000430762.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bellavite, Paolo. "Homeopathic Treatments of Upper Respiratory and Otorhinolaryngologic Infections: A Review of Randomized and Observational Studies." Alternative, Complementary & Integrative Medicine 5, no. 2 (2019): 1–20. http://dx.doi.org/10.24966/acim-7562/100068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brands, Martien. "Relevance or plausibility? Health care and research recommendations." International Journal of High Dilution Research - ISSN 1982-6206 17, no. 2 (2021): 28. http://dx.doi.org/10.51910/ijhdr.v17i2.935.

Full text
Abstract:
Background: Several disease indications have been researched for homeopathic treatment. However, the degree of evidence of studies is not yet investigated for the whole of homeopathic care. Three levels of care are identified: 1. Basic/ community health level. 2. Professional/ primary care level, 3. Advanced/ specialist care level
 Methods: Browser searches were made to identify studies at the three levels; from major reviews the last 20 years. The degrees of evidence were further subdivided into the levels of care. Each care level was documented for 7 major areas of pathology: cardiovascular, respiratory, gastro intestinal, urogenital, Neuro-endocrino-immunological, infectious, degenerative-oncological diseases. Criteria for inclusion: for RCT’s a minimum of Jadad score 3. 
 Results: A matrix yields an overview of studies of sufficient quality to make recommendations for health services to integrate homeopathic treatment into their package of service delivery. 75% of the included studies are performed at community health level only.
 Discussion: A disproportionate segment of RCT’s on community health level has been conducted, in relation to the actual teaching priorities on individual treatment in homeopathic practice, and professional profiling as ‘specialists’. External and model validity enhancing recommendations for RCTs are provided, and some disease-categories with sufficient evidence presented.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Respiratory infections - Homeopathic treatment"

1

Neumark, Thomas. "Treatment of Respiratory Tract Infections in Primary Care with special emphasis on Acute Otitis Media." Doctoral thesis, Linköpings universitet, Allmänmedicin, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-54832.

Full text
Abstract:
Background and aims: Most respiratory tract infections (RTI) are self-limiting. Despite this, they are associated with high antibiotic prescription rates in general practice in Sweden. The aim of this thesis was to evaluate the management of respiratory tract infections (RTIs) with particular emphasis on acute otitis media (AOM). Methods: Paper I: A prospective, open, randomized study of 179 children presenting with AOM and performed in primary care. Paper II & III: Study of 6 years data from primary care in Kalmar County on visits for RTI, retrieved from electronic patient records. Paper IV: Observational, clinical study of 71 children presenting with AOM complicated by perforation, without initial use of antibiotics. Results: Children with AOM who received PcV had some less pain, used fewer analgesics and consulted less, but the PcV treatment did not affect the recovery time or complication rate (I). Between 1999 and 2005, 240 445 visits for RTI were analyzed (II & III). Antibiotics were prescribed in 45% of visits, mostly PcV (60%) and doxycycline (18%). Visiting rates for AOM and tonsillitis declined by >10%/year, but prescription rates of antibiotics remained unchanged. For sore throat, 65% received antibiotics. Patients tested but without presence of S.pyogenes received antibiotics in 40% of cases. CRP was analyzed in 36% of consultations for RTI. At CRP<50mg/l antibiotics, mostly doxycycline, were prescribed in 54% of visits for bronchitis. Roughly 50% of patients not tested received antibiotics over the years.Twelve of 71 children with AOM and spontaneous perforation completing the trial received antibiotics during the first nine days due to lack of improvement, one child after 16 days due to recurrent AOM and six had new incidents of AOM after 30 days (IV). Antibiotics were used more frequently when the eardrum appeared pulsating and secretion was purulent and abundant. All patients with presence of S.pyogenes received antibiotics. Results: Children with AOM who received PcV had some less pain, used fewer analgesics and consulted less, but the PcV treatment did not affect the recovery time or complication rate (I). Between 1999 and 2005, 240 445 visits for RTI were analyzed (II & III). Antibiotics were prescribed in 45% of visits, mostly PcV (60%) and doxycycline (18%). Visiting rates for AOM and tonsillitis declined by >10%/year, but prescription rates of antibiotics remained unchanged. For sore throat, 65% received antibiotics. Patients tested but without presence of S.pyogenes received antibiotics in 40% of cases. CRP was analyzed in 36% of consultations for RTI. At CRP<50mg/l antibiotics, mostly doxycycline, were prescribed in 54% of visits for bronchitis. Roughly 50% of patients not tested received antibiotics over the years.Twelve of 71 children with AOM and spontaneous perforation completing the trial received antibiotics during the first nine days due to lack of improvement, one child after 16 days due to recurrent AOM and six had new incidents of AOM after 30 days (IV). Antibiotics were used more frequently when the eardrum appeared pulsating and secretion was purulent and abundant. All patients with presence of S.pyogenes received antibiotics.
APA, Harvard, Vancouver, ISO, and other styles
2

Idahosa, Lewis. "Treatment of Respiratory Tract Infections with a Pelargonium sidoides Extract (EPs® 7630) : - Literature study." Thesis, Umeå universitet, Kemiska institutionen, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-71125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

De, Kwaadsteniet Michele. "Characterization of nisin F and its role in the control of respiratory tract and skin infections." Thesis, Stellenbosch : University of Stellenbosch, 2009. http://hdl.handle.net/10019.1/1285.

Full text
Abstract:
Thesis (PhD (Microbiology))--University of Stellenbosch, 2009.<br>Multidrug resistant strains of Staphylococcus aureus is presenting an increasing threat, especially immune compromised individuals. Many of these strains have developed resistance to newly approved drugs such as quinupristin-dalfopristin, linezolid and daptomycin. The search for alternative treatment, including bacteriocins (ribosomally synthesized antimicrobial peptides) of lactic acid bacteria is increasing . Lactococcus lactis subsp. lactis F10, isolated from freshwater catfish, produced a new nisin variant active against clinical strains of S. aureus. The operon encoding nisin F is located on a plasmid and the structural gene has been sequenced. The lantibiotic is closely related to nisin Z, except at position 30 where valine replaced isoleucine. The antimicrobial activity of nisin F against S. aureus was tested in the respiratory tract of Wistar rats. Non-immunosuppressed and immunosuppressed rats were intranasally infected with S. aureus K and then treated with either nisin F or sterile physiological saline. Nisin F protected immunosuppressed rats against S. aureus, as symptoms of an infection were only detected in the trachea and lungs of immunosuppressed rats treated with saline. The safety of intranasally administered nisin F was also evaluated and proved to have no adverse side effects. The potential of nisin F as an antimicrobial agent to treat subcutaneous skin infections was evaluated by infecting C57BL/6 mice with a bioluminescent strain of S. aureus (Xen 36). Immunosuppressed mice were treated with either nisin F or sterile physiological saline 24 h and 48 h after infection with subcutaneously injected S. aureus Xen 36. Histology and bioluminescence flux measurements revealed that nisin F was ineffective in the treatment of deep dermal staphylococcal infections. Non-infected and infected mice treated with nisin F had an influx of polymorphonuclear cells in the deep stroma of the skin tissue. This suggested that nisin F, when injected subcutaneously, may have modulated the immune system. Nisin F proved an effective antimicrobial agent against S. aureus-related infections in the respiratory tract, but not against subcutaneous infections. The outcome of nisin F treatment thus depends on the route of administration and site of infection.
APA, Harvard, Vancouver, ISO, and other styles
4

Wheeler, Anthony John. "Upper respiratory tract infections, adenotonsillar hypertrophy and atopy in children : can adenotonsillectomy be avoided with medical treatment?" Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.428549.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mayerhofer, Raphaela. "Daratumumab treatment increases the risk of upper respiratory tract infections in multiple myeloma : A systematic review and meta-analysis." Thesis, Södertörns högskola, Miljövetenskap, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:sh:diva-41517.

Full text
Abstract:
Purpose This systematic review and meta-analysis was conducted to investigate the risk of upper respiratory tract infection in multiple myeloma patients undergoing antineoplastic therapy with the anti-CD38 monoclonal antibody Daratumumab. Methods PubMed, CINAHL, and Scopus databases were searched for publications describing rate of upper respiratory tract infections in multiple myeloma patients treated with Daratumumab. Covidence.org was used as a framework to conduct the evidence synthesis, the statistical calculations were performed in RStudio. Results Patients receiving Daratumumab to treat multiple myeloma are 1.63 times more likely to suffer from upper respiratory tract infections. Conclusion Daratumumab significantly increases the risk of upper respiratory tract infections in multiple myeloma patients. Healthcare providers should be aware of this risk and take appropriate measures to protect and educate multiple myeloma patients undergoing Daratumumab treatment.
APA, Harvard, Vancouver, ISO, and other styles
6

Dunder, T. (Teija). "Environment and atopy and asthma in childhood:the effect of dietary fats, common infections and asthma treatment practises on morbidity rates." Doctoral thesis, University of Oulu, 2008. http://urn.fi/urn:isbn:9789514287510.

Full text
Abstract:
Abstract Despite the common recommendations of the criteria for the diagnosis of asthma there is still a wide variation within different regions in diagnoses, use of medications and hospitalisation rates especially among young children. This thesis elucidates the role of spesified environmental risk factors associated with the development of atopic diseases in childhood. In two prospective follow-up surveys we found that allergies and asthma associate with the consumption of margarines, butter and fish and that the common infection of childhood, RS-virus infection, does not increase asthma morbidity in adolescence. In a randomised set-up we were able to verify that the common childhood infections do not protect from allergies and asthma. In a retrospective survey we found that hospitalisation rates can reflect medication practices in different regions. Our results indicate that consumption of fat in the diet can be one triggering factor for allergies but common childhood infections are merely markers of susceptibility to allergies and asthma rather than the cause of it.
APA, Harvard, Vancouver, ISO, and other styles
7

Thomann, Andreas [Verfasser], and Rolf W. [Akademischer Betreuer] Hartmann. "Discovery and development of anti-infectives with novel modes of action for the treatment of respiratory tract infections / Andreas Thomann ; Betreuer: Rolf W. Hartmann." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2017. http://d-nb.info/1127039849/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Motsamai, Itumeleng George. "The efficacy of Linctagon® Forte Capsules on the symptoms of colds and influenza in female resident students at the University of Johannesburg." Thesis, 2013. http://hdl.handle.net/10210/8410.

Full text
Abstract:
M.Tech. (Homoeopathy)<br>The common cold is an acute viral infection of the respiratory tract, usually afebrile in nature. It is characterized by inflammation of the airways (Beers and Porter 2006). Influenza, commonly referred to as “flu”, is an acute and highly contagious viral infection of the respiratory tract. It is easily spread by sneezing and coughing (Balch, 2006). Conventional medication typically includes: aspirin, nasal decongestants, antihistamines, non-steroidal anti-inflammatory drugs and antiviral drugs, but these substances may produce unwanted side-effects. If a secondary bacterial infection develops, antibiotics are added (Beers, 2003). Linctagon® Forte Capsules are a self-help proprietary medication by Nativa containing Pelargonium sidoides, Quercetin, Bromelain and Zinc, and is used for the treatment of colds and influenza (Nativa, 2011), but further research is required for this product. The aim of this study was to determine the efficacy of Linctagon® Forte Capsules on the symptoms of colds and influenza of female resident students between the ages of eighteen and thirty five years at the University of Johannesburg. Efficacy was determined by means of a modified “Severity of Symptoms Questionnaire” and a modified “Quality of Life Questionnaire”. Thirty female participants, aged between 18 and 35 years, with symptoms of common cold and influenza, were recruited in this double-blind, placebo-controlled randomized study, according to the inclusion and exclusion criteria. Participants were recruited by means of advertising flyers and posters at the University of Johannesburg (UJ) campuses as well as the University of Johannesburg female residences. Participants that presented with any of the common cold or influenza symptoms were to immediately contact the researcher to set up an initial interview. The study was conducted over an eight day period with a total of three consultations. During the first consultation, the participants were requested to sign a “Participant Profile Form”, a “Participant Information and Consent Form” and undergo the relevant physical examinations. Participants were then given either the placebo capsules or the Linctagon® Forte Capsules and instructed to take one capsule three times daily. Participants were also requested to complete a modified “Severity of Symptoms Questionnaire” and a modified “Quality of Life Questionnaire” every evening for the duration of the study. All data collected during the study was statistically analysed using Chi Square as well as the Descriptive Analysis (Smith, 2011).
APA, Harvard, Vancouver, ISO, and other styles
9

Bhika, Jyoti. "Efficacy of Linctagon® Forte capsules in the treatment of cold and influenza symptoms on first and second year students from the University of Johannesburg." Thesis, 2013. http://hdl.handle.net/10210/8657.

Full text
Abstract:
M.Tech. (Homeopathy)<br>The common cold and influenza (flu) are both acute viral infections affecting the upper respiratory tract (Beers & Porter, 2006). The common cold typically presents with rhinorrhea, sneezing, and a sore throat (Kansal & Kaushal, 2004), and influenza causes fever, coryza, cough, headache, malaise and body pain (Beers & Porter, 2006). Millions of school and work days are missed annually due to cold and influenza symptoms (Fendrick et al., 2003). Students at universities have a high incidence of colds and influenza due to raised levels of stress and close contact with other infected individuals (Zachary, 2006). Researchers believe that Interleukin-6 (a protein in the body responsible for co-ordination of immune response) may be a biological link between psychological stress and the severity of cold and influenza symptoms. This may make students more susceptible to the common cold and influenza (Mercola, 1999). Conventional treatment for both conditions is comprised of analgesics, antipyretics, antibiotics, non-steroidal anti-inflammatory drugs or anti-viral drugs, all of which have numerous adverse effects (Roxas & Jurenka, 2007). Linctagon® Forte capsules consists of four ingredients: Pelargonium sidoides (333mg), Quercetin (80mg), Bromelain (53mg) and Zinc (5mg) and are purported to provide antiviral support in the treatment of colds and influenza. The aim of this eight-day, double-blind, placebo-controlled study was to assess the efficacy of Linctagon® Forte Capsules in the treatment of cold and influenza symptoms on first and second year Health Sciences students from the University of Johannesburg. Thirty seven students from the first and second year Health Sciences Faculty of the University of Johannesburg, suffering from common cold or influenza symptoms, were recruited to participate. This included male and female students between the ages of 18 to 30 years. Advertisements (Appendix A) were placed at the UJ Health Training Centre, classrooms and on campus, with relevant permission given. Thirty participants completed the study and seven students did not complete due to poor compliance. The inclusion and exclusion criteria were dealt with by completion of a Participant Information and Consent Form (Appendix B) as well as a Participant Profile Form which recorded all initial symptoms (Appendix C). All participants were required to have a minimum of five of the ten symptoms represented on the Participant Profile form (Appendix C). Once participants were accepted into the study they were allocated to either Group A or Group B, with 15 participants in each group. The medication bottles were packaged and labelled by Nativa (24 capsules in a 100mg container), and the active medication and the placebo were randomised by means of a coding system, Batch “A” and Batch “B”. Group A received the Linctagon® Forte Capsules and Group B received the unmedicated lactose capsules. The participants were requested to take 1 capsule three times per day. Each participant was given eight Symptom Score Cards (Appendix D) to complete each card every morning and evening for the eight day period, to rate the severity of their symptoms according to a 5-point rating system. The influenza and common cold symptoms were analysed according to their decrease in frequency and intensity over the set period of time. Data was only recorded and analysed for days one to seven due to poor compliance by participants in both groups with regards to completion of the Symptom Score Cards towards the end of the study. Both the treatment (Group A) and the placebo (Group B) groups showed similar improvement in symptom severity over the entire research period, and there was no statistical significance between the two groups. This shows neither group outperformed the other, supporting the null hypothesis. Small sample size, the placebo effect and low dosages of certain of the active ingredients are possible factors involved in the results seen, and should be considered for future studies.
APA, Harvard, Vancouver, ISO, and other styles
10

Bourdette, Francois Mbongo Rafemo. "The efficacy of Linctagon® spray for the prevention of colds and Influenza in female soccer team players of the University of Johannesburg." Thesis, 2013. http://hdl.handle.net/10210/8320.

Full text
Abstract:
M.Tech. (Homoeopathy)<br>The common cold and influenza (flu) are upper respiratory tract conditions; the former characterized by nasal or throat discomfort, sneezing, rhinorrhoea, and malaise, and the latter by fever, coryza, anorexia, cough, headache, malaise and myalgia (Beers et al., 2006). The common cold can be caused by over 200 rhinoviruses while influenza is mostly due to influenza virus A or B. Cold symptoms usually clear after 7-10 days, influenza which is more severe lasts for 2-3 weeks (Eccles, 2005). Athletes are susceptible to common colds and influenza infections due to intensive physical activities and stress, which lowers their immune systems and increases the risk of spread among team-mates. To avoid missing competitions and practice, it would be advantageous for athletes to receive prophylactic treatment during the high risk period for colds and flu such as in winter (Brukner and Khan, 2006). Pelargonium sidoides, which is an ingredient of Linctagon® spray, is a well-researched plant extract which has antiviral, antibacterial and immune-modulator effects (Nativa, 2011). Its effect as a prophylactic for athletes has not been researched. The aim of this study was to determine the efficacy of Linctagon® spray in preventing common colds and influenza in female soccer teams of the University of Johannesburg. This was a double-blind, placebo-controlled study, which took place over 63 days. Thirty female participants aged between 18-30 years were recruited from the University of Johannesburg female soccer teams via direct recruitment during training sessions on the University of Johannesburg Bunting campus. Participants meeting the inclusion criteria completed the Participant Information, Profile and Consent Forms. On day 1, the participants underwent a physical examination (vitals, ear, nose, throat and chest examinations). Participants either received a 20 ml bottle of Linctagon® spray or a placebo spray. Five squirts were taken orally twice daily for nine weeks. Participants also received three Wellness Questionnaires and Health Questionnaires to complete at home weekly and returned these at the following visits. On day 21 and day 42, the researcher collected the completed Questionnaires, performed a physical examination, dispensed and gave participants additional medication, and three additional Wellness and Health Questionnaires. At the final consultation, day 63, the researcher collected the questionnaires, and did a fourth and final physical examination. The data was collected from the participants and analyzed according to group frequencies and independent T-tests. The outcome indicated that the placebo was equally as effective as Linctagon® spray in the prophylaxis of common cold and influenza infections in female soccer team players of the University of Johannesburg for the duration of the study.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Respiratory infections - Homeopathic treatment"

1

Respiratory syncytial virus: Prevention, diagnosis and treatment. Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Blasi, Francesco. Textbook of respiratory and critical care infections. Jaypee Brothers Medical Publishers, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kapoor, R. K. Control AIDS thru homoeopathy. Ocean Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Block, Mary Ann. No more Amoxicillin: Preventing and treating ear and respiratory infections without antibiotics. Kensington Books, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

zhao chu man xing ke sou de zhen xiang. 2nd ed. He ji tu shu chu ban she, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Simpson, Sue. A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection. University of Birmingham, Department of Public Health and Epidemiology, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

File, Thomas. New insights in the treatment of severe infections in the multiple-drug resistant situation: Proceedings of a satellite symposium to the 11th International Congress on Infectious Diseases, Cancun, Mexico, March 5, 2004. Karger, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

The neti pot for better health. Healthy Living Publications, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

American College of Physicians (2003- ). Clinical practice: American College of Physicians guidelines and U.S. Preventive Service Task Force recommendations. Edited by Snow Vincenza 1961- and U.S. Preventive Services Task Force. American College of Physicians, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Acute Respiratory Infections. Oxford University Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Respiratory infections - Homeopathic treatment"

1

Tattersfield, Anne E., and Martin W. McNicol. "Lower Respiratory Tract Infections." In Treatment in Clinical Medicine. Springer London, 1987. http://dx.doi.org/10.1007/978-1-4471-3132-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ball, Peter, and Lionel Mandell. "Treatment of Community-Acquired Respiratory Tract Infections." In Quinolone Antimicrobial Agents. ASM Press, 2014. http://dx.doi.org/10.1128/9781555817817.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mills, John. "Prevention and Treatment of Respiratory Syncytial Virus Infections." In Antiviral Chemotherapy 5. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4743-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Low, Donald E. "Fluoroquinolones for the treatment of respiratory tract infections other than pneumonia." In Milestones in Drug Therapy. Birkhäuser Basel, 2003. http://dx.doi.org/10.1007/978-3-0348-8103-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bothamley, Graham H., and Penny Shaw. "The Diagnosis and Treatment of Respiratory Infections in Autoimmune Disease, Excluding Tuberculosis." In Autoimmune Aspects of Lung Disease. Birkhäuser Basel, 1998. http://dx.doi.org/10.1007/978-3-0348-8926-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mangiarotti, P., and C. Grassi. "Intravenous Ciprofloxacin for the Treatment of Lower Respiratory Tract Infections: Preliminary Results." In Ciprofloxacin i.v. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-79098-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Knight, V., and B. Gilbert. "Ribavirin Aerosol Treatment of Influenza, Respiratory Syncytial and Parainfluenza Virus Infections of Man." In Clinical Use of Antiviral Drugs. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1715-9_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Seki, Masafumi. "Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What Are the Mechanisms of Secondary Bacterial Pneumonia?" In Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-9109-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sperber, S. J., and F. G. Hayden. "Perspectives in the Use of Antiviral Agents for Prevention and Treatment of Respiratory Virus Infections." In Clinical Use of Antiviral Drugs. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1715-9_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Degnan, Tina H., and Neil S. Skolnik. "Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Infections, Rhinosinusitis, and Acute Bronchitis in Adults." In Essential Practice Guidelines in Primary Care. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-313-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Respiratory infections - Homeopathic treatment"

1

Saez, Gualberto Díaz, Susana Conde Diez, Ana Viejo Casas, and Sylvaine Balmy. "A Homeopathic Medication Can Improve Upper Respiratory Tract Infections in COPD Patients: EPOXILO Cohorts Study." In HRI London 2019—Cutting Edge Research in Homeopathy: Presentation Abstracts. The Faculty of Homeopathy, 2020. http://dx.doi.org/10.1055/s-0040-1702064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Saunders, J., R. F. Relich, L. Smith, B. Gaston, and M. D. Davis. "A Safe Inhaled Alkaline Treatment That Inhibits Respiratory Viral Infections." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Majmudar, P., D. B. Sanders, J. Slaven, and A. I. Cristea. "Outpatient Treatment of Lower Respiratory Tract Infections in Children with Tracheostomy - A Single Institution Experience." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rattinger, Gail B., C. D. Mullins, Eberechukwu Onukwugh, Ilene H. Zuckerman, Loreen Walker, and Sylvain DeLisle. "Clinical Decision Support At Time Of Prescribing To Decrease Inappropriate Antibiotics Prescribing For Treatment Of Acute Respiratory Infections." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Peyrani, Paula, Ahmed Nahas, Vanina Giovini, et al. "Respiratory Viruses Are Significant Etiologic Agents In Hospitalized Patients With Lower Respiratory Tract Infections: Results From The Rapid Empiric Treatment With Oseltamivir Study (RETOS)." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1796.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Taylor, JA, DS Han, CE Hovis, et al. "Comparison of Two Nebulized Silver Carbene Complexes, SCC1 and SCC5, as Treatment of Respiratory Infections in a Mouse Model ofPseudomonas aeruginosaPneumonia." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5959.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lozitsky, V., A. Fedchuk, T. Grydina, et al. "Proteolysis Inhibitor E-Aminocaproic Acid as Effective Drug for Prevention and Treatment of Influenza, Other Acute Respiratory Viral Infections and their Bacterial Complications." In 1st International Electronic Conference on Medicinal Chemistry. MDPI, 2015. http://dx.doi.org/10.3390/ecmc-1-a050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hava, David L., Lester C. Griel, Wesley H. DeHaan, et al. "Inhaled Cationic Airway Lining Modulator (iCALM) Therapy, A Novel Aerosol Treatment For Respiratory Infections Reduces Clinical Symptoms And Transmission Of Influenza A Infection." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6846.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fatony, Riska Fajar, Didik Gunawan Tamtomo, and Hanung Prasetya. "The Effect Echinacea Purpurea Herbs in Reducing Symptoms of Upper Respiratory Infection: A Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.58.

Full text
Abstract:
Background: Echinacea possibly reduces the effectiveness of corticosteroids, commonly used by asthmatics and for treating viral induced wheeze, and can cause hypersensitivity reactions in susceptible individuals. Treatment of the common cold in children with Echinacea has only been investigated in one randomized, double blind, placebo controlled trial to examine the efficacy and safety of Echinacea purpurea in children with upper respiratory tract infections. This study aimed to investigate the effect Echinacea purpurea herbs in reducing symptoms of upper respiratory infection. Subjects and Method: This was meta-analysis and systematic review. The study was conducted by collecting published articles from PubMed, Science Direct, and Google Scholar databases. The study subject was adults with upper respiratory infection. Intervention was Echinecea purpurea herbs extract with comparison placebo. The study outcome was decreased symptoms of upper respiratory tract infection. The inclusion criteria were full text, using English language, and using randomized controlled trial. The collected articles were selected by PRISMA flow chart. The quantitative data were analyzed using Revman 5.3 Results: A meta-analysis using 6 studies from United States resulted high heterogeneity between experimental groups (I2= 98%; p&lt;0.001), so it conducted by random effect model (REM). This study showed that provision of Echinecea purpurea herbs extract reduced symptoms of upper respiratory tract infection than placebo (Mean Difference= -0.56; 95% CI= -0.91 to -0.22; p= 0.001). Conclusion: Echinecea purpurea herbs extract reduced symptoms of upper respiratory tract infection than placebo. Keywords: Echinacea purpurea herbs extract, upper respirstory infection Correspondence: Riska Fajar Fatony. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: respatieka10@gmail.com. Mobile: +6289508588008. DOI: https://doi.org/10.26911/the7thicph.05.58
APA, Harvard, Vancouver, ISO, and other styles
10

Zahra, R., A. A. Khan, and M. Sajid. "Hydrodynamic Evaluation of Microtiter Plate Assay Using Computational Fluid Dynamics for Biofilm Formation." In ASME-JSME-KSME 2019 8th Joint Fluids Engineering Conference. American Society of Mechanical Engineers, 2019. http://dx.doi.org/10.1115/ajkfluids2019-5425.

Full text
Abstract:
Abstract Biofilms are complex surface associated communities where bacterial cells are enclosed by self-produced extra cellular polymeric substances (EPS), mainly consisting of exopolysaccharides, proteins and extracellular DNA. Treatment of biofilm associated persistent infections is an emerging issue for clinicians as bacterial cells adhere with human epithelial cells or indwelling medical devices such as implants and catheters, used in urinary tract and respiratory infections. Several methods are in practice to assess the biofilm formation of bacterial strains. Most of these are phenotypic methods which include Congo red assay (CRA), Air liquid interface (ALI), tissue culture plate method and Microtiter plate assay (MTPA). MTPA is considered as a standard screening method for comparing adherence pattern and is the most widely used quantitative method for detection of biofilm formation. Generally, the assay is performed under standard static conditions and little is known about the hydrodynamics in the microtiter plates. A few studies have applied computational fluid dynamics (CFD) simulations to describe flow pattern in microtiter plates during biofilm production and optimized the suitable conditions to detect the biofilm formation which have proven to be efficient. In this work the dependencies of biofilm formation on the hydrodynamics in microtiter plate assays were evaluated using OpenFOAM® an open-source toolbox for numerical simulation. It was found that higher flow rates increase the nutrient availability, promote cell growth, and attachment pattern with increased production of exopolymer, while the increase in flow velocity increases the shear rate causing erosion and disassembly of biofilm production because of detachment from the surface.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography